POU5F1 and acute myeloid leukemia: In prostate cancer, rectal cancer, glioma, melanoma, medulloblastoma, acute myeloid leukaemia and other cancer types, high OCT4 mRNA or protein expression was related with poor clinical outcomes (Mohiuddin et al., 2020).